- Home
- RFL vs RAND Comparison
RFL vs RAND Comparison
Compare RFL & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- RAND
- Stock Information
- Founded
- RFL 2017
- RAND 1969
- Country
- RFL United States
- RAND United States
- Employees
- RFL N/A
- RAND N/A
- Industry
- RFL Real Estate
- RAND Finance: Consumer Services
- Sector
- RFL Finance
- RAND Finance
- Exchange
- RFL Nasdaq
- RAND Nasdaq
- Market Cap
- RFL 48.4M
- RAND 47.5M
- IPO Year
- RFL N/A
- RAND N/A
- Fundamental
- Price
- RFL $2.32
- RAND $17.13
- Analyst Decision
- RFL
- RAND
- Analyst Count
- RFL 0
- RAND 0
- Target Price
- RFL N/A
- RAND N/A
- AVG Volume (30 Days)
- RFL 65.0K
- RAND 2.1K
- Earning Date
- RFL 12-12-2024
- RAND 11-04-2024
- Dividend Yield
- RFL N/A
- RAND 6.77%
- EPS Growth
- RFL N/A
- RAND 72.67
- EPS
- RFL N/A
- RAND 4.19
- Revenue
- RFL $540,000.00
- RAND $7,874,601.00
- Revenue This Year
- RFL N/A
- RAND N/A
- Revenue Next Year
- RFL N/A
- RAND N/A
- P/E Ratio
- RFL N/A
- RAND $4.09
- Revenue Growth
- RFL 92.86
- RAND 13.24
- 52 Week Low
- RFL $1.29
- RAND $12.50
- 52 Week High
- RFL $2.50
- RAND $19.60
- Technical
- Relative Strength Index (RSI)
- RFL 80.52
- RAND 52.43
- Support Level
- RFL $2.00
- RAND $16.58
- Resistance Level
- RFL $1.94
- RAND $17.26
- Average True Range (ATR)
- RFL 0.10
- RAND 0.29
- MACD
- RFL 0.03
- RAND 0.09
- Stochastic Oscillator
- RFL 77.78
- RAND 86.87
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.